Q2 2015

Source filing unavailable

Q2 2015 · —

Revenue—

Net Income

-$28.61M

N/M vs Q2 2014

EPS Diluted

-$0.47

N/M vs Q2 2014

Operating Income-$27,952,000N/M

Operating Cash Flowderived-$24,240,000N/M

Free Cash Flowderived

Same quarter

Metric	Q2 2015	Q2 2014	Q2 2013	Q2 2012
Revenue	—	—	$11.50M	$0.00
Net Income	-$28.61M	-$23.22M	-$8.85M	-$9.70M
EPS Diluted	-$0.47	-$0.59	-$0.28	-$0.39

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR